BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25660217)

  • 1. OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.
    Cotton F; Kremer S; Hannoun S; Vukusic S; Dousset V;
    J Neuroradiol; 2015 Jun; 42(3):133-40. PubMed ID: 25660217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.
    Vukusic S; Casey R; Rollot F; Brochet B; Pelletier J; Laplaud DA; De Sèze J; Cotton F; Moreau T; Stankoff B; Fontaine B; Guillemin F; Debouverie M; Clanet M
    Mult Scler; 2020 Jan; 26(1):118-122. PubMed ID: 30541380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.
    Brocard G; Casey R; Dufay N; Marignier R; Michel L; Hisbergues M; Ayrignac X; Lehmann S; Thouvenot E; Gallot G; Collongues N; Herpe YE; Lebrun-Frenay C; Cotton F; De Sèze J; Guillemin F; Moreau T; Pelletier J; Stankoff B; Vukusic S; Zephir H; Laplaud D;
    Mult Scler Relat Disord; 2023 Sep; 77():104872. PubMed ID: 37453261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
    Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
    J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study.
    Wilson S; Calocer F; Rollot F; Fauvernier M; Remontet L; Tron L; Vukusic S; Le Page E; Debouverie M; Ciron J; Ruet A; De Sèze J; Zephir H; Moreau T; Lebrun-Frénay C; Laplaud DA; Clavelou P; Labauge P; Berger E; Pelletier J; Heinzlef O; Thouvenot E; Camdessanché JP; Leray E; Dejardin O; Defer G
    Lancet Reg Health Eur; 2023 Jan; 24():100542. PubMed ID: 36426377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on brain MRI for the diagnosis and follow-up of MS patients.
    Brisset JC; Vukusic S; Cotton F;
    Presse Med; 2021 Jun; 50(2):104067. PubMed ID: 33989722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
    Kolind S; Seddigh A; Combes A; Russell-Schulz B; Tam R; Yogendrakumar V; Deoni S; Sibtain NA; Traboulsee A; Williams SC; Barker GJ; Brex PA
    Neuroimage Clin; 2015; 9():574-80. PubMed ID: 26594633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years-Protocol, recruitment status, and baseline characteristics.
    Vukusic S; Bourre B; Casey R; Deiva K; Guennoc AM; Lebrun-Frenay C; Leray E; Rollot F; Benyahya L; Girod C; Marignier R; Maillart E
    Mult Scler; 2024 Feb; 30(2):216-226. PubMed ID: 38205811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI.
    Roca P; Attye A; Colas L; Tucholka A; Rubini P; Cackowski S; Ding J; Budzik JF; Renard F; Doyle S; Barbier EL; Bousaid I; Casey R; Vukusic S; Lassau N; Verclytte S; Cotton F; ; ; ;
    Diagn Interv Imaging; 2020 Dec; 101(12):795-802. PubMed ID: 32651155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI to detect and localize the area postrema in multiple sclerosis: The role of 3D-DIR and 3D-FLAIR.
    Farges V; Hannoun S; Benini T; Marignier R; Cotton F
    J Neuroimaging; 2021 Jul; 31(4):701-705. PubMed ID: 33930239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis].
    Rovira A; Tintoré M; Alvarez-Cermeño JC; Izquierdo G; Prieto JM
    Neurologia; 2010 May; 25(4):248-65. PubMed ID: 20609303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time.
    Jacobi C; Hähnel S; Martinez-Torres F; Rieger S; Jüttler E; Heiland S; Jarius S; Meyding-Lamadè U; Storch-Hagenlocher B; Wildemann B
    Eur J Neurol; 2008 Dec; 15(12):1359-64. PubMed ID: 19049554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI of spinal cord in multiple sclerosis.
    Agosta F; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():46S-49S. PubMed ID: 17425735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Barro C; Benkert P; Disanto G; Tsagkas C; Amann M; Naegelin Y; Leppert D; Gobbi C; Granziera C; Yaldizli Ö; Michalak Z; Wuerfel J; Kappos L; Parmar K; Kuhle J
    Brain; 2018 Aug; 141(8):2382-2391. PubMed ID: 29860296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R; Dandamudi VS; Neema M; De C; Bermel RA
    J Neuroimaging; 2005; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal Cord in Multiple Sclerosis: Magnetic Resonance Imaging Features and Differential Diagnosis.
    Rovira A; Auger C
    Semin Ultrasound CT MR; 2016 Oct; 37(5):396-410. PubMed ID: 27616313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.